|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of ezetmibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: aprospective, randomized, double-blind trial显示文摘 | Ballantyne CM Houri J Notarbartolo A | 2003 | Circulation2003，107，19： | 1 |
| 2 | Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hype-rcholesterolemia: a prospective, randomized, double-blind trial 显示文摘 | BALLANTYNE C M HOURI J NOTARBARTOLO A | 2003 | Circulation2003，107，： | 1 |
| 3 | Effect of ezetimibe coadminis-tered with atorvastatin in628patients with primary hypercholesterolemia:a prospective,randomized,double-blind trial显示文摘 | Ballantyne CM Houri J Notarbartolo A | 2003 | Circulation2003，107，： | 1 |
| 4 | Effect of Ezetimibe eoadministered with Atorvastatin in 628 patients with primary hypercholesterolemia a prospective, randomized, double- blind trial显示文摘 | Ballantyne CM Houri J Notarbartolo A | 2003 | Circulation2003，107，19： | 1 |
| 5 | Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia显示文摘 | Davi G Avena M | 1995 | Arterioscler Thromb Vasc Bioi1995，15，： | 1 |
| 6 | Effect of ezetimibe coadministration with atorvastatin in 628 patients with primary hypercholesterolenia: a prospective, randomized, double-blind trial 显示文摘 | Ballantyne CM Houri J Notarbartolo A | 2003 | Circulation2003，107，19： | 1 |
| 7 | Inhibition of thromboxanebiosynthesis and platelet function by simvastatin in type IIahypercholesterolemia显示文摘 | Notarbartolo A Davi G Averna M | 1995 | Arterioscler Thromb Vasc Biol1995，15，2： | 1 |
| 8 | Influence of CYP3A5 and ABCBI gene polymorpbisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients 显示文摘 | Provenzani A Notarbartolo M Labbozzetta M | 2011 | lnt J Mol Med2011，28，6： | 1 |
| 9 | Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients显示文摘 | Provenzani A Notarbartolo M Labbozzetta M | 2011 | Int J Mol Med2011，28，6： | 1 |
| 10 | Effect of ezetimibe coadministered with atovastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial 显示文摘 | Ballantyne CM Houri J Notarbartolo A | 2003 | Circulation2003，107，19： | 1 |
| 11 | Effect of eze-timibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia:a prospective,randomized,double-blind trial显示文摘 | Ballantyne CM Houri J Notarbartolo A | | 0，，19： | 1 |
| 12 | Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia a prospective,randomized,double-blind trial显示文摘 | Ballantyne CM Houri J Notarbartolo A | 2003 | Circulation2003，107，： | 1 |
| 13 | Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial显示文摘 | BallantyneCM Houri J Notarbartolo A | 2003 | Circulation2003，107，： | 1 |
| 14 | The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients显示文摘 | Provenzani A Notarbartolo M Labbozzetta M | 2009 | Ann Transplant2009，14，1： | 1 |
| 15 | Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia:a prospective,randomized,double-blind trial显示文摘 | BALLANTYNE C M HOURI J NOTARBARTOLO A | 2003 | Circulation2003，107，： | 1 |
| 16 | Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomlzed, double - blind trial显示文摘 | Ballantyne CM Houri J Notarbartolo A | 2003 | Circulation2003，2，19： | 1 |
| 17 | In- fluence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients显示文摘 | Provenzani A Notarbartolo M Labbozzetta M | 2011 | Int J Mol Med2011，28，6： | 1 |
| 18 | Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial显示文摘 | BALLANTYNE CM HOURI J NOTARBARTOLO A | 2003 | Circulation2003，107，19： | 1 |
| 19 | Inhibition of the omboxan biosynthesis and platelet function by simvastation in type II a type cholesterolemia 显示文摘 | Notarbartolo A Davi G Averna M | 1995 | Arterioscl Thromb Vase Bio1995，15，2： | 1 |
| 20 | Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia显示文摘 | Ballantyne CM Houri J Notarbartolo A | 2003 | Circulation2003，107，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员